G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	118.95	102.06	72.4	7.38	-19.88	-14.3
Depreciation & Amortization	10.43	10.38	9.33	9.4	9.33	9.21
Other Amortization	-	-	-	-	0	0
Loss (Gain) From Sale of Assets	0.01	0.01	0.01	0	0.02	0.01
Other Operating Activities	22.27	22.5	17.98	0.71	1.67	-2.51
Change in Accounts Receivable	-3.32	-3.04	-14.19	4.38	1.08	-2.22
Change in Inventory	-5.38	1.2	1.74	-5.69	-2.85	0.14
Change in Accounts Payable	0.16	1.42	-2	2.47	-0.35	0.35
Change in Unearned Revenue	24.7	-10.01	23.39	71.39	0.28	0
Change in Other Net Operating Assets	9.35	10.16	4.82	9.92	1.52	10.09
Operating Cash Flow	177.17	134.68	113.48	99.96	-9.19	0.77
Operating Cash Flow Growth	33.54%	18.68%	13.52%	-	-	-
Capital Expenditures	-5.92	-5.92	-5.52	-2.95	-1.77	-5
Sale (Purchase) of Intangibles	-0.03	-0.08	-	-0.01	-0.22	-1.77
Investment in Securities	-140.61	-83.05	-82.04	5.4	9	15.9
Other Investing Activities	-0.19	-0.19	-0.87	0.07	-	-0.01
Investing Cash Flow	-146.75	-89.24	-88.43	2.51	7.01	9.13
Long-Term Debt Repaid	-	-0.77	-0.12	-	-	-
Net Debt Issued (Repaid)	-0.82	-0.77	-0.12	-	-	-
Common Dividends Paid	-31.76	-31.76	-	-	-	-
Financing Cash Flow	-32.58	-32.54	-0.12	-	-	-
Net Cash Flow	-2.17	12.9	24.94	102.47	-2.18	9.9
Free Cash Flow	171.25	128.76	107.96	97.01	-10.96	-4.23
Free Cash Flow Growth	32.56%	19.26%	11.29%	-	-	-
Free Cash Flow Margin	62.55%	51.70%	59.50%	150.15%	-44.61%	-14.98%
Free Cash Flow Per Share	2.91	2.18	1.83	1.64	-0.19	-0.07
Cash Interest Paid	0.04	0.04	0	-	-	-
Cash Income Tax Paid	0.15	0.15	0.02	-	-	-
Levered Free Cash Flow	122.27	82.35	67.88	93.19	-5.52	-7.17
Unlevered Free Cash Flow	122.3	82.37	67.88	93.19	-5.52	-7.17
Change in Net Working Capital	-32.95	-3.22	-13.64	-83.33	0.64	-0.05

Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.